Holen Sie sich die Stockscreener-App
7.08
2.46%
0.17
Schlusskurs vom Vortag:
$6.91
Offen:
$6.77
24-Stunden-Volumen:
49,757
Relative Volume:
0.02
Marktkapitalisierung:
$14.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+12.38%
1M Leistung:
+20.82%
6M Leistung:
+25.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$6.77
$7.2407
1-Wochen-Bereich:
$5.91
$7.2407
52-Wochen-Spanne:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Vergleichen Sie QNTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
7.08 | 14.35M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
153.47 | 65.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 46.99B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.18 | 45.96B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.87 | 17.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
291.38 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Press Release Distribution & PR Platform - ACCESS Newswire
Quantum BioPharma to Reveal Year-End Results and Key Regulatory Milestones in May 6 Update - Stock Titan
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time - GlobeNewswire
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time - GlobeNewswire Inc.
Quantum BioPharma adds Kevin Malone as advisor By Investing.com - Investing.com South Africa
Quantum BioPharma adds Kevin Malone as advisor - Investing.com
Quantum Biopharma Announces Advocate Against Naked Short - GlobeNewswire
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin - Bluefield Daily Telegraph
Quantum BioPharma Strengthens Defense: Short Selling Expert Kevin Malone to Combat Market Manipulation - Stock Titan
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Lithium Argentina to Release First Quarter 2025 Results on May 14, 2025 - The Globe and Mail
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Ignore - The Globe and Mail
Quantum BioPharma Secures Legal Victory with $180,000 Award - TipRanks
Quantum BioPharma wins legal battle against former CEO - Investing.com
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario - GlobeNewswire
Latest: Court Upholds $2.8M Award in Quantum BioPharma's Favor Against Former CEO - Stock Titan
2 AI Stocks That Could Help Set You Up for Life - The Globe and Mail
3 ETFs to Save Your Portfolio Right Now - The Globe and Mail
Are These 3 Retail Stocks Oversold or Really in Trouble? - The Globe and Mail
Should You Buy ChargePoint While It's Below $0.70? - The Globe and Mail
BMO Announces Election of Board of Directors - The Globe and Mail
Stocks in play: Bonterra Energy Corp - The Globe and Mail
Time to Load Up on the New Look of SCHD - The Globe and Mail
1 Undervalued Growth Stock You Can Buy During the Stock Market Drop of 2025 - The Globe and Mail
3 Reasons to Avoid SWIM and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Pa - GuruFocus
Quantum BioPharma’s licensee expands retail reach with AATAC deal By Investing.com - Investing.com South Africa
Quantum BioPharma Licensee Celly Nutrition Partners With Asian American Trade Associations Council - marketscreener.com
Quantum BioPharma's licensee expands retail reach with AATAC deal By Investing.com - Investing.com India
Quantum BioPharma's licensee expands retail reach with AATAC deal - Investing.com
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™ - GlobeNewswire
Quantum's Alcohol Detox Drink Lands Massive Deal: Coming to 80,000+ US Stores - Stock Titan
NYSE Content Advisory: Pre-Market update + NYSE-listed Delta Air Lines reports earnings - The Globe and Mail
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Es liegen keine Finanzdaten für Quantum Biopharma Ltd (QNTM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):